CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...
As buzzwords like “holistic care” and “patient-centric” have solidified into value-based care models and total capitation contracts, providers and payers still face a lot of friction to align ...
The Centers for Medicare and Medicaid Services aims to have all Medicare beneficiaries in a value-based arrangement by 2030. But achieving that will be a difficult undertaking, with just 12% of ...
Acquisition strengthens Lightbeam's AI-enabled operating system for value-based care by integrating Syntax's innovative incentive modeling platform and adds actuarial services DALLAS, Dec. 4, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results